Fulvestrant [fulvestrant]
topical
57
- Terms
-
Faslodex
-
7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol
Faslodex
ICI 182,780
ICI 182780
ICI-182780
ZM 182780
ZM-182780
Persistent link
https://www.medvik.cz/link/D000077267
Definition
An estradiol derivative and estrogen receptor antagonist that is used for the treatment of estrogen receptor-positive, locally advanced or metastatic breast cancer.
- DUI
- D000077267 MeSH Browser
- CUI
- M0397101
- History note
- 2019 (1991)
- Public note
- 2019; FULVESTRANT was indexed under ESTRADIOL/analogs & derivatives 1991-2019
Allowable subheadings
- AD
- administration & dosage 17
- AE
- adverse effects 7
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 2
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 7
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 18
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D04.210
Fused-Ring Compounds
D04.210.500.365.415.248.830
2-Methoxyestradiol
D06.472.334.851.437.500.750
2-Methoxyestradiol